A
Acrivon Therapeutics (ACRV)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acrivon Therapeutics (ACRV)
Acrivon Therapeutics, Inc. is a United States-based is a clinical-stage oncology therapeutics company. The Company provides technologies driving precision-based medicine. It leverages its phosphoproteomics technology called Acrivon Precision Predicti... Read more
- USD6.91
- USD7.17
- USD6.85
- USD11.90
- -18.20%
- --
- 111.91k
- 151.89k
- 222M
- 3.19
- -19.90%
Stock News
yesterday
East and Gulf Coast ports strike deal is not close to done: Automation still a big hurdle in ILA/USMX negotiations
CNBC
yesterday
Why Cisco is looking at investing in CoreWeave, a hot AI startup
MarketWatch
yesterday
Next steps for the Fed after strong jobs data — plus, news on health and beer stocks
CNBC
yesterday
Selena Gomez couldn’t afford to go to her first Disney casting—now she’s a billionaire startup founder
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
